On June 15, 2025, AHEA was proud to co-host the Global Biopharma Leadership Forum at Harvard Medical School, alongside IntelliPro, BayHelix Group, CSSA@HMS, and MSQ Ventures, with generous support from BioCentury and UHY.
As one of the most forward-looking executive gatherings surrounding BIO 2025, the Forum convened nearly 30 senior leaders from global pharma, emerging biotech, top VC/PE firms, and strategic advisors. The agenda was tightly focused and deeply insightful—featuring keynote panels, company showcases, and collaborative case discussions across four critical themes:
🔹 Navigating Biopharma in a Shifting Geopolitical Landscape — Long-term strategy in a new era of policy and capital realignment 💬 Featuring: @Echo Hindle-Yang, @Josh Berlin, @Nikhil Mutyal, @Alex Coghill, @Jens Bitsch-Northave, @Weiyong Sun
🔹 The Rise of Mega Rounds in Biotech Investment — Rational capital deployment and new windows in a cooling primary market 💬 Featuring: @Linda Zhao, @Chong Xu, @Lou Kassa, @Joan Shen, @Pengpeng Li
🔹 AI Breakthroughs in Drug Development — How generative AI is transforming decision-making and pipeline acceleration 💬 Featuring: @Alan Jiang, @Rui Tang, @Zhiyong Xie, @Ming Tommy Tang, @Ma (Gary) Dong
🔹 Global Development Collaboration Case Studies — From dependency to innovation in cross-border partnering models 💬 Featuring: @Wendy Pan, @Shanshan Xu, @Jimmy Zhang, @Alvin Luk, @Yao Zhang, @Wu ChenBing
🚀 Company Showcases Thank you to the visionary founders and executives who presented: @Sung Hwan Moon (Aptabio), @Chongyi Yu (Techfields), @Jing Wang (Myro), @Shirley Liu (GV20), @Alex Shagianian (HitGen)
🤝 This forum was more than a deep dive into industry trends—it served as a vital platform for meaningful dialogue, cross-border collaboration, and forward-thinking partnership.
👏 AHEA extends our sincere appreciation to all speakers, partners, and participants who contributed to this dynamic and high-impact gathering. We remain committed to fostering global innovation and collaboration across the life sciences ecosystem.
On January 11, 2026, during J.P. Morgan Healthcare Week, the American Healthcare Executive Association (AHEA) convened senior leaders from across global biopharma in San Francisco for the 2026 Global Biopharma Leadership Forum — creating a trusted platform for strategic exchange ahead of the industry’s most influential gathering of the year.
On January 11, 2026, during J.P. Morgan Healthcare Week, American Healthcare Executive Association was proud to partner with bioSeedin to co-host the BIOseedin Winter Innovation Partnering Summit in San Francisco.
On June 15, 2025, AHEA was proud to co-host the Global Biopharma Leadership Forum at Harvard Medical School, alongside IntelliPro, BayHelix Group, CSSA@HMS, and MSQ Ventures, with generous support from BioCentury and UHY.
On June 14, 2025, during the BIO International Convention, AHEA was honored to co-host the Executive Workshop at PwC Boston Headquarters, in partnership with PwC, IntelliPro, BayHelix, and MSQ Ventures.
It was a pleasure to co-host the “NewCo & Out-Licensing” forum with Jones Day and IntelliPro bringing together leaders from biotech, pharma, and investment to explore cross-border collaboration and global expansion strategies.
We are thrilled to announce the resounding success of the AHEA Summit 2024, held in conjunction with JPM2024. This event has marked a significant milestone in our journey towards healthcare innovation and global collaboration.
contact@ahea.io